Celadon Pharmaceuticals Plc (LON:CEL – Get Free Report)’s share price shot up 8% during trading on Thursday . The company traded as high as GBX 37.80 ($0.50) and last traded at GBX 35.11 ($0.46). 138,896 shares traded hands during trading, an increase of 143% from the average session volume of 57,163 shares. The stock had previously closed at GBX 32.50 ($0.43).
Celadon Pharmaceuticals Price Performance
The company has a debt-to-equity ratio of 148.29, a current ratio of 2.62 and a quick ratio of 6.97. The stock has a market cap of £25.69 million, a price-to-earnings ratio of -352.73 and a beta of -0.12. The stock has a fifty day moving average of GBX 56.46 and a 200 day moving average of GBX 83.04.
Celadon Pharmaceuticals Company Profile
Celadon Pharmaceuticals Plc engages in the research, cultivation, manufacturing, and sale of cannabis-based medicines. The company primarily focuses on growing indoor hydroponic cannabis for use in medicinal products used to treat chronic pain, as well as autism spectrum disorders. Celadon Pharmaceuticals Plc was founded in 2018 and is headquartered in London, the United Kingdom.
Further Reading
- Five stocks we like better than Celadon Pharmaceuticals
- There Are Different Types of Stock To Invest In
- Does A&F’s Q2 Earnings Win Point to a Strong Holiday Season?
- How to Calculate Options Profits
- Best Buy Stock Flashes Bullish Signal, Challenges Remain
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Affirm Shows Buy-Now-Pay-Later Is Here to Stay in Latest Results
Receive News & Ratings for Celadon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celadon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
